Cargando…

pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures

MOTIVATION: G protein-coupled receptors (GPCRs) can selectively bind to many types of ligands, ranging from light-sensitive compounds, ions, hormones, pheromones and neurotransmitters, modulating cell physiology. Considering their role in many essential cellular processes, they are one of the most t...

Descripción completa

Detalles Bibliográficos
Autores principales: Velloso, João Paulo L, Ascher, David B, Pires, Douglas E V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651072/
https://www.ncbi.nlm.nih.gov/pubmed/34901870
http://dx.doi.org/10.1093/bioadv/vbab031
_version_ 1784611333406195712
author Velloso, João Paulo L
Ascher, David B
Pires, Douglas E V
author_facet Velloso, João Paulo L
Ascher, David B
Pires, Douglas E V
author_sort Velloso, João Paulo L
collection PubMed
description MOTIVATION: G protein-coupled receptors (GPCRs) can selectively bind to many types of ligands, ranging from light-sensitive compounds, ions, hormones, pheromones and neurotransmitters, modulating cell physiology. Considering their role in many essential cellular processes, they are one of the most targeted protein families, with over a third of all approved drugs modulating GPCR signalling. Despite this, the large diversity of receptors and their multipass transmembrane architectures make the identification and development of novel specific, and safe GPCR ligands a challenge. While computational approaches have the potential to assist GPCR drug development, they have presented limited performance and generalization capabilities. Here, we explored the use of graph-based signatures to develop pdCSM-GPCR, a method capable of rapidly and accurately screening potential GPCR ligands. RESULTS: Bioactivity data (IC50, EC50, Ki and Kd) for individual GPCRs were curated. After curation, we used the data for developing predictive models for 36 major GPCR targets, across 4 classes (A, B, C and F). Our models compose the most comprehensive computational resource for GPCR bioactivity prediction to date. Across stratified 10-fold cross-validation and blind tests, our approach achieved Pearson’s correlations of up to 0.89, significantly outperforming previous methods. Interpreting our results, we identified common important features of potent GPCRs ligands, which tend to have bicyclic rings, leading to higher levels of aromaticity. We believe pdCSM-GPCR will be an invaluable tool to assist screening efforts, enriching compound libraries and ranking candidates for further experimental validation. AVAILABILITY AND IMPLEMENTATION: pdCSM-GPCR predictive models and datasets used have been made available via a freely accessible and easy-to-use web server at http://biosig.unimelb.edu.au/pdcsm_gpcr/. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics Advances online.
format Online
Article
Text
id pubmed-8651072
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86510722021-12-08 pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures Velloso, João Paulo L Ascher, David B Pires, Douglas E V Bioinform Adv Original Article MOTIVATION: G protein-coupled receptors (GPCRs) can selectively bind to many types of ligands, ranging from light-sensitive compounds, ions, hormones, pheromones and neurotransmitters, modulating cell physiology. Considering their role in many essential cellular processes, they are one of the most targeted protein families, with over a third of all approved drugs modulating GPCR signalling. Despite this, the large diversity of receptors and their multipass transmembrane architectures make the identification and development of novel specific, and safe GPCR ligands a challenge. While computational approaches have the potential to assist GPCR drug development, they have presented limited performance and generalization capabilities. Here, we explored the use of graph-based signatures to develop pdCSM-GPCR, a method capable of rapidly and accurately screening potential GPCR ligands. RESULTS: Bioactivity data (IC50, EC50, Ki and Kd) for individual GPCRs were curated. After curation, we used the data for developing predictive models for 36 major GPCR targets, across 4 classes (A, B, C and F). Our models compose the most comprehensive computational resource for GPCR bioactivity prediction to date. Across stratified 10-fold cross-validation and blind tests, our approach achieved Pearson’s correlations of up to 0.89, significantly outperforming previous methods. Interpreting our results, we identified common important features of potent GPCRs ligands, which tend to have bicyclic rings, leading to higher levels of aromaticity. We believe pdCSM-GPCR will be an invaluable tool to assist screening efforts, enriching compound libraries and ranking candidates for further experimental validation. AVAILABILITY AND IMPLEMENTATION: pdCSM-GPCR predictive models and datasets used have been made available via a freely accessible and easy-to-use web server at http://biosig.unimelb.edu.au/pdcsm_gpcr/. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics Advances online. Oxford University Press 2021-11-10 /pmc/articles/PMC8651072/ /pubmed/34901870 http://dx.doi.org/10.1093/bioadv/vbab031 Text en © The Author(s) 2021. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Velloso, João Paulo L
Ascher, David B
Pires, Douglas E V
pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures
title pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures
title_full pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures
title_fullStr pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures
title_full_unstemmed pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures
title_short pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures
title_sort pdcsm-gpcr: predicting potent gpcr ligands with graph-based signatures
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651072/
https://www.ncbi.nlm.nih.gov/pubmed/34901870
http://dx.doi.org/10.1093/bioadv/vbab031
work_keys_str_mv AT vellosojoaopaulol pdcsmgpcrpredictingpotentgpcrligandswithgraphbasedsignatures
AT ascherdavidb pdcsmgpcrpredictingpotentgpcrligandswithgraphbasedsignatures
AT piresdouglasev pdcsmgpcrpredictingpotentgpcrligandswithgraphbasedsignatures